The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells
Open accessAbstract
Significance: Interleukin-33 (IL-33) is an IL-1 family cytokine with important roles in type-2 immunity and human asthma. IL-33 is a key activator of the recently described group-2 innate lymphoid cells (ILC2s), which are involved in the initiation of allergic inflammation. Here, we investigated the mechanisms regulating IL-33 activity. We discovered that mast cells, critical effector cells in allergic disorders, secrete proteases, which cleave IL-33 and generate mature forms with increased biological activity. We demonstrate that these mature forms of IL-33 are 30-fold more potent than full-length IL-33 for activation of ILC2s. Our study suggests that inhibition of IL-33 cleavage by mast cell and other inflammatory proteases could be useful to limit IL-33–mediated responses in allergic asthma and other inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,710
Innate lymphoid cells — a proposal for uniform nomenclature
Spits, H., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J. P., Eberl, G., Koyasu, S., Locksley, R. M., McKenzie, A. N. J., Mebius, R. E., et al. (2013) · Nature Reviews Immunology · doi:10.1038/nri3365 · Cited by 2,389
Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H., Furusawa, J.-I., Ohtani, M., Fujii, H., & Koyasu, S. (2010) · Nature · doi:10.1038/nature08636 · Cited by 1,992
The interleukin-1 family: back to the future
Garlanda, C., Dinarello, C. A., & Mantovani, A. (2013) · Immunity · doi:10.1016/j.immuni.2013.11.010 · Cited by 1,945
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M., Langford, T. K. A., Bucks, C., Kane, C. M., Fallon, P. G., Pannell, R., et al. (2010) · Nature · doi:10.1038/nature08900 · Cited by 1,938
A large-scale, consortium-based genomewide association study of asthma
Moffatt, M. F., Gut, I. G., Demenais, F., Strachan, D. P., Bouzigon, E., Heath, S., von Mutius, E., Farrall, M., Lathrop, M., & Cookson, W. O. C. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0906312 · Cited by 1,818
Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus
Monticelli, L. A., Sonnenberg, G. F., Abt, M. C., Alenghat, T., Ziegler, C. G. K., Doering, T. A., Angelosanto, J. M., Laidlaw, B. J., Yang, C. Y., Sathaliyawala, T., et al. (2011) · Nature Immunology · doi:10.1038/ni.2131 · Cited by 1,321
Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus
Monticelli (2011) · PubMed · doi:10.1031/ni.2131 · Cited by 1,286
Mast cells in the development of adaptive immune responses
Galli, S. J., Nakae, S., & Tsai, M. (2005) · Nature Immunology · doi:10.1038/ni1158 · Cited by 1,279
Moussion, C., Ortega, N., & Girard, J.-P. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003331 · Cited by 1,179
Self-citationMjösberg, J. M., Trifari, S., Crellin, N. K., Peters, C. P., van Drunen, C. M., Piet, B., Fokkens, W. J., Cupedo, T., & Spits, H. (2011) · Nature Immunology · doi:10.1038/ni.2104 · Cited by 1,166
Systemically dispersed innate IL-13–expressing cells in type 2 immunity
Price, A. E., Liang, H.-E., Sullivan, B. M., Reinhardt, R. L., Eisley, C. J., Erle, D. J., & Locksley, R. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003988107 · Cited by 1,131
Type 2 innate lymphoid cells control eosinophil homeostasis
Nussbaum, J. C., Van Dyken, S. J., von Moltke, J., Cheng, L. E., Mohapatra, A., Molofsky, A. B., Thornton, E. E., Krummel, M. F., Chawla, A., Liang, H.-E., et al. (2013) · Nature · doi:10.1038/nature12526 · Cited by 1,068
Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain
Cao, X., Shores, E. W., Hu-Li, J., Anver, M. R., Kelsail, B. L., Russell, S. M., Drago, J., Noguchi, M., Grinberg, A., Bloom, E. T., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90047-0 · Cited by 1,038
Disease-associated functions of IL-33: the new kid in the IL-1 family
Liew, F. Y., Pitman, N. I., & McInnes, I. B. (2010) · Nature Reviews Immunology · doi:10.1038/nri2692 · Cited by 1,003
A role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis
Salimi, M., Barlow, J. L., Saunders, S. P., Xue, L., Gutowska-Owsiak, D., Wang, X., Huang, L.-C., Johnson, D., Scanlon, S. T., McKenzie, A. N. J., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130351 · Cited by 979
Carriere, V., Roussel, L., Ortega, N., Lacorre, D.-A., Americh, L., Aguilar, L., Bouche, G., & Girard, J.-P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606854104 · Cited by 966 · cited 7×
“Our study identifies the central cleavage/activation domain of IL-33 (amino acids 66–111) as an important functional domain of the protein and suggests that interference with IL-33 cleavage and activation by mast cell and other inflammatory proteases could be useful to reduce IL-33–mediated responses in allergic asthm…”
BackgroundSelf-citationMolofsky, A. B., Nussbaum, J. C., Liang, H.-E., Van Dyken, S. J., Cheng, L. E., Mohapatra, A., Chawla, A., & Locksley, R. M. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121964 · Cited by 874
Halim, T. Y. F., Krauß, R. H., Sun, A. C., & Takei, F. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.020 · Cited by 804
Chang, Y.-J., Kim, H. Y., Albacker, L. A., Baumgarth, N., McKenzie, A. N. J., Smith, D. E., DeKruyff, R. H., & Umetsu, D. T. (2011) · Nature Immunology · doi:10.1038/ni.2045 · Cited by 777
TSLP Elicits IL-33–Independent Innate Lymphoid Cell Responses to Promote Skin Inflammation
Kim, B. S., Siracusa, M. C., Saenz, S. A., Noti, M., Monticelli, L. A., Sonnenberg, G. F., Hepworth, M. R., Van Voorhees, A. S., Comeau, M. R., & Artis, D. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005374 · Cited by 731
The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1
Cayrol, C., & Girard, J.-P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812690106 · Cited by 707
Self-citationSuppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases
Lüthi, A. U., Cullen, S. P., McNeela, E. A., Duriez, P. J., Afonina, I. S., Sheridan, C., Brumatti, G., Taylor, R. C., Kersse, K., Vandenabeele, P., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.007 · Cited by 677
Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction
Gudbjartsson, D. F., Bjornsdottir, U. S., Halapi, E., Helgadottir, A., Sulem, P., Jonsdottir, G. M., Thorleifsson, G., Helgadottir, H., Steinthorsdottir, V., Stefansson, H., et al. (2009) · Nature Genetics · doi:10.1038/ng.323 · Cited by 677
IL-33 is a crucial amplifier of innate rather than acquired immunity
Oboki, K., Ohno, T., Kajiwara, N., Arae, K., Morita, H., Ishii, A., Nambu, A., Abe, T., Kiyonari, H., Matsumoto, K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003059107 · Cited by 652
IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G
Lefrançais, E., Roga, S., Gautier, V., Gonzalez-de-Peredo, A., Monsarrat, B., Girard, J.-P., & Cayrol, C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115884109 · Cited by 594
Self-citationBartemes, K. R., Iijima, K., Kobayashi, T., Kephart, G. M., McKenzie, A. N., & Kita, H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102832 · Cited by 549 · cited 3×
“Finally, we determined the impact of mast cell protease inhibition on the activity of endogenous IL-33 in vivo, using a model of allergic inflammation induced by the clinically relevant fungal allergen Alternaria alternata (21).”
BackgroundMethodResultCutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells
Roediger, B., Kyle, R., Yip, K. H., Sumaria, N., Guy, T. V., Kim, B. S., Mitchell, A. J., Tay, S. S., Jain, R., Forbes-Blom, E., et al. (2013) · Nature Immunology · doi:10.1038/ni.2584 · Cited by 492
Baekkevold, E. S., Roussigné, M., Yamanaka, T., Johansen, F.-E., Jahnsen, F. L., Amalric, F., Brandtzaeg, P., Erard, M., Haraldsen, G., & Girard, J.-P. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63631-0 · Cited by 474
Self-citationBarlow, J. L., Bellosi, A., Hardman, C. S., Drynan, L. F., Wong, S. H., Cruickshank, J. P., & McKenzie, A. N. J. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.09.041 · Cited by 474
Pichery, M., Mirey, E., Mercier, P., Lefrancais, E., Dujardin, A., Ortega, N., & Girard, J.-P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101977 · Cited by 466
Self-citationCutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells
Allakhverdi, Z., Smith, D. E., Comeau, M. R., & Delespesse, G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2051 · Cited by 431
Imai, Y., Yasuda, K., Sakaguchi, Y., Haneda, T., Mizutani, H., Yoshimoto, T., Nakanishi, K., & Yamanishi, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307321110 · Cited by 431
Mast cell proteases: multifaceted regulators of inflammatory disease
Pejler, G., Rönnberg, E., Waern, I., & Wernersson, S. (2010) · Blood · doi:10.1182/blood-2010-01-257287 · Cited by 378
Yasuda, K., Muto, T., Kawagoe, T., Matsumoto, M., Sasaki, Y., Matsushita, K., Taki, Y., Futatsugi-Yumikura, S., Tsutsui, H., Ishii, K. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201042109 · Cited by 321
Roussel, L., Erard, M., Cayrol, C., & Girard, J. (2008) · EMBO reports · doi:10.1038/embor.2008.145 · Cited by 300
Self-citationVan Dyken, S. J., Mohapatra, A., Nussbaum, J. C., Molofsky, A. B., Thornton, E. E., Ziegler, S. F., McKenzie, A. N. J., Krummel, M. F., Liang, H.-E., & Locksley, R. M. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.003 · Cited by 251
Hardman, C. S., Panova, V., & McKenzie, A. N. J. (2013) · European Journal of Immunology · doi:10.1002/eji.201242863 · Cited by 242
A critical role of IL-33 in experimental allergic rhinitis
Haenuki, Y., Matsushita, K., Futatsugi-Yumikura, S., Ishii, K. J., Kawagoe, T., Imoto, Y., Fujieda, S., Yasuda, M., Hisa, Y., Akira, S., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.02.013 · Cited by 233
Structural insights into the interaction of IL-33 with its receptors
Liu, X., Hammel, M., He, Y., Tainer, J. A., Jeng, U.-S., Zhang, L., Wang, S., & Wang, X. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308651110 · Cited by 213
IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms
Hung, L.-Y., Lewkowich, I. P., Dawson, L. A., Downey, J., Yang, Y., Smith, D. E., & Herbert, D. R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206587110 · Cited by 206
Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation
Bessa, J., Meyer, C. A., de Vera Mudry, M. C., Schlicht, S., Smith, S. H., Iglesias, A., & Cote-Sierra, J. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.02.012 · Cited by 169
Roy, A., Ganesh, G., Sippola, H., Bolin, S., Sawesi, O., Dagälv, A., Schlenner, S., Feyerabend, T. B., Rodewald, H.-R., Kjellén, L., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.435156 · Cited by 133
Waern, I., Lundequist, A., Pejler, G., & Wernersson, S. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.129 · Cited by 122
Strik, M. C. M., de Koning, P. J. A., Kleijmeer, M. J., Bladergroen, B. A., Wolbink, A. M., Griffith, J. M., Wouters, D., Fukuoka, Y., Schwartz, L. B., Hack, C. E., et al. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.03.024 · Cited by 116
Human mast cells drive memory CD4+ T cells toward an inflammatory IL-22+ phenotype
Gaudenzio, N., Laurent, C., Valitutti, S., & Espinosa, É. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.01.029 · Cited by 70
Regulation of chymase production in human mast cell progenitors
Ahn, K., Takai, S., Pawankar, R., Kuramasu, A., Ohtsu, H., Kempuraj, D., Tomita, H., Iida, M., Matsumoto, K., Akasawa, A., et al. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.108107 · Cited by 63
Efficient cytokine-induced IL-13 production by mast cells requires both IL-33 and IL-3
Junttila, I., Watson, C., Kummola, L., Chen, X., Hu‐Li, J., Guo, L., Yagi, R., & Paul, W. E. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.03.033 · Cited by 58
Cited by
Overview of the IL ‐1 family in innate inflammation and acquired immunity
Dinarello, C. A. (2018) · Immunological Reviews · doi:10.1111/imr.12621 · Cited by 1,866
Interleukin-33 in health and disease
Liew, F. Y., Girard, J.-P., & Turnquist, H. R. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.95 · Cited by 1,147
Self-citationInterleukin‐33 (IL‐33): A nuclear cytokine from the IL‐1 family
Cayrol, C., & Girard, J. (2018) · Immunological Reviews · doi:10.1111/imr.12619 · Cited by 879
Self-citationNew developments in mast cell biology
Kalesnikoff, J., & Galli, S. J. (2008) · Nature Immunology · doi:10.1038/ni.f.216 · Cited by 748
Mast cells as sources of cytokines, chemokines, and growth factors
Mukai, K., Tsai, M., Saito, H., & Galli, S. J. (2018) · Immunological Reviews · doi:10.1111/imr.12634 · Cited by 682
Metadata
- Authors
- Lefrançais, E., Duval, A., Mirey, E., Roga, S., Espinosa, E., Cayrol, C., & Girard, J.-P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2014-10-13
- Volume
- 111
- Issue
- 43
- Pages
- 15502-15507
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2069609111
- Cited by
- 384
- References
- 48
- FWCI
- 9.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.